ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.

Yanlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.